Influenza Virus Nucleoprotein Antikörper (Influenza A Virus)
Kurzübersicht für Influenza Virus Nucleoprotein Antikörper (Influenza A Virus) (ABIN966400)
Target
Alle Influenza Virus Nucleoprotein (IV NP) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Ascitic fluid
-
Immunogen
- Purified recombinant fragment of Influenza A virus nucleoprotein expressed in E. Coli strain BL21(DE3)
-
-
-
-
Applikationshinweise
-
Western Bloting: 1/500 - 1/2000.
ELISA: Propose dilution 1/10000.
Not yet tested in other applications.
Determining optimal working dilutions by titration test. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
-
-
: "The hypervariable immunodominant NP418-426 epitope from the influenza A virus nucleoprotein is recognized by cytotoxic T lymphocytes with high functional avidity." in: Journal of virology, Vol. 80, Issue 12, pp. 6024-32, (2006) (PubMed).
: "Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events." in: Virology, Vol. 328, Issue 1, pp. 101-19, (2004) (PubMed).
-
-
- Influenza Virus Nucleoprotein (IV NP)
-
Andere Bezeichnung
- Influenza A (Nucleoprotein)
-
Substanzklasse
- Influenza Protein
-
Hintergrund
- Influenza A and B are the two types of influenza viruses that cause epidemic human disease. Influenza type C infections cause a mild respiratory illness and are not thought to cause epidemics. Influenza A viruses are further categorized into subtypes on the basis of two surface antigens: hemagglutinin (H) and neuraminidase (N). Strains are also described by geographic origin, strain number and year of isolation.
Target
-